How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
Saved in:
| Title: | How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature. |
|---|---|
| Authors: | Alan, Ozkan1 ozkan.alan@hotmail.com, Kuzhan, Okan2, Koca, Sinan3, Telli, Tugba Akin1, Basoglu, Tugba1, Ercelep, Ozlem1, Filinte, Deniz4, Sengul, Yildiz5, Arikan, Huseyin6, Kaya, Serap1, Babacan, Nalan Akgul1, Dane, Faysal1, Yumuk, Perran Fulden1 |
| Source: | Journal of Oncology Pharmacy Practice. Jun2020, Vol. 26 Issue 4, p1011-1018. 8p. 2 Color Photographs, 2 Black and White Photographs, 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10781552 |
|---|---|
| DOI: | 10.1177/1078155219879757 |
